Biohaven shares are trading lower after B of A Securities downgraded the stock from Neutral to Underperform and lowered its price target from $12 to $11.

Benzinga Newsdesk www.benzinga.com Negative 97.2%

Neg 97.2% Neu 0% Pos 0%

Comments

No comments yet. Be the first!